Jesse A Berlin

Q: What Schools Are Affiliated With Jesse A Berlin

Jesse A Berlin is affiliated with the following schools: Rutgers University, Stanford University, University of Pennsylvania, Harvard University

Jesse A Berlin's AcademicInfluence.com Rankings

Jesse A Berlin

Engineering

#2851

World Rank

#3840

Historical Rank

Cybernetics

#29

World Rank

#33

Historical Rank

Biomedical Engineering

#98

World Rank

#99

Historical Rank

engineering Degrees

Download Badge

Engineering

Jesse A Berlin's Degrees

PhD Biomedical Engineering Stanford University
Masters Biomedical Engineering Stanford University

Why Is Jesse A Berlin Influential?

(Suggest an Edit or Addition)

(See a Problem?)

Jesse A Berlin's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

Meta-analysis of observational studies in epidemiology: a proposal for reporting. Meta-analysis Of Observational Studies in Epidemiology (MOOSE) group. (2000) (17470)
SPIRIT 2013 statement: defining standard protocol items for clinical trials. (2013) (3679)
SPIRIT 2013 explanation and elaboration: guidance for protocols of clinical trials (2013) (3035)
Publication bias in clinical research (1991) (2845)
The effect of race and sex on physicians' recommendations for cardiac catheterization. (1999) (1833)
A meta-analysis of physical activity in the prevention of coronary heart disease. (1990) (1448)
Meta-analysis of Observational Studies in Epidemiology (2000) (1353)
The association between hepatitis C infection and survival after orthotopic liver transplantation. (2002) (1031)
Defining the clinically important difference in pain outcome measures (2000) (981)
Effect of anaemia and cardiovascular disease on surgical mortality and morbidity (1996) (949)
Efficacy and safety of quinidine therapy for maintenance of sinus rhythm after cardioversion. A meta-analysis of randomized control trials. (1990) (907)
Effect of testosterone treatment on body composition and muscle strength in men over 65 years of age. (1999) (817)
Much ado about nothing: a comparison of the performance of meta‐analytical methods with rare events (2007) (812)
The epidemiology and attributable outcomes of candidemia in adults and children hospitalized in the United States: a propensity analysis. (2005) (776)
Effect of testosterone treatment on bone mineral density in men over 65 years of age. (1999) (771)
Publication bias : a problem in interpreting medical data (1988) (756)
SPIRIT 2013 Statement: defining standard protocol items for clinical trials. (2015) (688)
Effects of testosterone replacement in hypogonadal men. (2000) (646)
The Use of Predicted Confidence Intervals When Planning Experiments and the Misuse of Power When Interpreting Results (1994) (616)
Prevalence and treatment of psoriasis in the United Kingdom: a population-based study. (2005) (604)
Meta‐analysis of Epidemiologic Dose‐Response Data (1993) (512)
Meta-analysis: state-of-the-science. (1992) (502)
The continuing unethical conduct of underpowered clinical trials. (2002) (483)
What contributions do languages other than English make on the results of meta-analyses? (2000) (470)
Prevention of supraventricular arrhythmias after coronary artery bypass surgery. A meta-analysis of randomized control trials. (1991) (469)
Mortality and complications associated with laparoscopic cholecystectomy. A meta-analysis. (1996) (467)
Does blinding of readers affect the results of meta-analyses? (1997) (456)
Adjustments for Center in Multicenter Studies: An Overview (2001) (432)
Perioperative blood transfusion and postoperative mortality. (1998) (427)
Clinically important changes in acute pain outcome measures: a validation study. (2003) (426)
A comparison of statistical methods for combining event rates from clinical trials. (1989) (410)
Publication bias and dissemination of clinical research. (1989) (408)
Individual patient‐ versus group‐level data meta‐regressions for the investigation of treatment effect modifiers: ecological bias rears its ugly head (2002) (406)
Healing of diabetic neuropathic foot ulcers receiving standard treatment. A meta-analysis. (1999) (379)
The CLASI (Cutaneous Lupus Erythematosus Disease Area and Severity Index): an outcome instrument for cutaneous lupus erythematosus. (2005) (373)
A meta-analysis of alcohol consumption in relation to risk of breast cancer. (1988) (349)
A Proposal for Reporting (2010) (342)
Hemodialysis vascular access morbidity in the United States. (1993) (331)
Effectiveness of platelet releasate for the treatment of diabetic neuropathic foot ulcers. (2001) (329)
An examination of research design effects on the association of testosterone and male aging: results of a meta-analysis. (1991) (313)
Morbidity and mortality from elective surgery for asymptomatic, unruptured, intracranial aneurysms: a meta-analysis. (1994) (312)
Revised estimates of diagnostic test sensitivity and specificity in suspected biliary tract disease. (1994) (275)
Oral contraceptives and the risk of breast cancer. (2002) (274)
Does masking author identity improve peer review quality? A randomized controlled trial. PEER Investigators. (1998) (261)
Lymphoma rates are low but increased in patients with psoriasis: results from a population-based cohort study in the United Kingdom. (2003) (250)
Predictors of common bile duct stones prior to cholecystectomy: a meta-analysis. (1996) (248)
National Institutes of Health State-of-the-Science Conference Statement: ERCP for diagnosis and therapy, January 14-16, 2002. (2002) (246)
Evaluation of the association between hereditary thrombophilias and recurrent pregnancy loss: a meta-analysis. (2004) (246)
Meta-regression detected associations between heterogeneous treatment effects and study-level, but not patient-level, factors. (2004) (244)
Screening Mammography in Women 40 to 49 Years of Age: A Systematic Review for the American College of Physicians (2007) (243)
Diabetic neuropathic foot ulcers: the association of wound size, wound duration, and wound grade on healing. (2002) (240)
Flaxseed and Cardiovascular Risk Factors: Results from a Double Blind, Randomized, Controlled Clinical Trial (2008) (237)
Factors influencing the optimal control-to-case ratio in matched case-control studies. (1999) (233)
Guidelines for the Content of Statistical Analysis Plans in Clinical Trials (2017) (231)
Effect of Antidepressants and Their Relative Affinity for the Serotonin Transporter on the Risk of Myocardial Infarction (2003) (230)
Risk factors associated with the failure of a venous leg ulcer to heal. (1999) (227)
Which venous leg ulcers will heal with limb compression bandages? (2000) (226)
Patients Exposed to Rofecoxib and Celecoxib Have Different Odds of Nonfatal Myocardial Infarction (2005) (224)
Relative risks and confidence intervals were easily computed indirectly from multivariable logistic regression. (2007) (224)
The accuracy of venous leg ulcer prognostic models in a wound care system (2004) (222)
Risk Factors for Infective Endocarditis: Oral Hygiene and Nondental Exposures (2000) (216)
Parenteral Ketorolac and Risk of Gastrointestinal and Operative Site Bleeding (1996) (209)
The Effect of Anesthetic Technique on Postoperative Outcomes in Hip Fracture Repair (2000) (205)
Erythropoiesis-stimulating agents in oncology: a study-level meta-analysis of survival and other safety outcomes (2010) (204)
The relationship between coronary angioplasty procedure volume and major complications. (1995) (201)
Comparative effects of carvedilol and metoprolol on left ventricular ejection fraction in heart failure: results of a meta-analysis. (2001) (194)
Invited commentary: benefits of heterogeneity in meta-analysis of data from epidemiologic studies. (1995) (190)
Incidence of infective endocarditis in the Delaware Valley, 1988-1990. (1995) (188)
Parenteral ketorolac and risk of gastrointestinal and operative site bleeding. A postmarketing surveillance study. (1997) (187)
Lifetime recreational exercise activity and breast cancer risk among black women and white women. (2005) (183)
Perioperative β-blocker withdrawal and mortality in vascular surgical patients (2001) (183)
Hormone Replacement Therapy Regimens and Breast Cancer Risk (2002) (177)
Empirical assessment of whether moderate payments are undue or unjust inducements for participation in clinical trials. (2004) (167)
Risk factors for delayed healing of neuropathic diabetic foot ulcers: a pooled analysis. (2000) (161)
Sleep Quality, Estradiol Levels, and Behavioral Factors in Late Reproductive Age Women (2001) (158)
Adverse event detection in drug development: recommendations and obligations beyond phase 3. (2008) (156)
Relation of regimens of combined hormone replacement therapy to lobular, ductal, and other histologic types of breast carcinoma (2002) (151)
Comparative effectiveness of canagliflozin, SGLT2 inhibitors and non‐SGLT2 inhibitors on the risk of hospitalization for heart failure and amputation in patients with type 2 diabetes mellitus: A real‐world meta‐analysis of 4 observational databases (OBSERVE‐4D) (2018) (150)
Searching one or two databases was insufficient for meta-analysis of observational studies. (2005) (140)
Evaluating the impact of database heterogeneity on observational study results. (2013) (139)
Factors affecting decisions to seek treatment for sick children in Kerala, India. (2003) (138)
Systematic review of the effect of daily alcohol intake on blood pressure. (2005) (137)
The Effect of Antilymphocyte Induction Therapy on Renal Allograft Survival (1998) (134)
Oral contraceptives and breast cancer review and meta‐analysis (1990) (134)
Effect of anti-lymphocyte induction therapy on renal allograft survival: a meta-analysis. (1997) (133)
Indications for and outcomes of cholecystectomy: a comparison of the pre and postlaparoscopic eras. (1998) (133)
The NICHD Women's Contraceptive and Reproductive Experiences Study: methods and operational results. (2002) (132)
Diabetic neuropathic foot ulcers and amputation (2005) (128)
Risk factors for early postoperative recurrence of Crohn's disease. (1998) (127)
An Assessment of Publication Bias Using a Sample of Published Clinical Trials (1989) (126)
Detection of proximal adenomatous polyps with screening sigmoidoscopy: a systematic review and meta-analysis of screening colonoscopy. (2003) (126)
Perioperative beta-blocker withdrawal and mortality in vascular surgical patients. (2001) (124)
Meta-analysis as evidence: building a better pyramid. (2014) (123)
Diabetic neuropathic foot ulcers: predicting which ones will not heal. (2003) (122)
The effects of nonselective non-aspirin non-steroidal anti-inflammatory medications on the risk of nonfatal myocardial infarction and their interaction with aspirin. (2004) (122)
Development and validation of a simplified predictive index for major complications in contemporary percutaneous transluminal coronary angioplasty practice (1995) (119)
Effect sizes for dichotomous data. (2009) (113)
Who reviews the reviewers? Feasibility of using a fictitious manuscript to evaluate peer reviewer performance. (1998) (112)
Antibiotic treatment of acne may be associated with upper respiratory tract infections. (2005) (109)
Dermatology position paper on the revision of the 1982 ACR criteria for systemic lupus erythematosus (2004) (108)
Comparability of perioperative morbidity between abdominal myomectomy and hysterectomy for women with uterine leiomyomas. (2000) (107)
Measuring the quality of trials: the quality of quality scales. (1999) (106)
Effect of transdermal testosterone treatment on serum lipid and apolipoprotein levels in men more than 65 years of age. (2001) (106)
Surrogate end points for the treatment of diabetic neuropathic foot ulcers. (2003) (103)
Regulatory approval of pharmaceuticals without a randomised controlled study: analysis of EMA and FDA approvals 1999–2014 (2016) (103)
Recommendations for safety planning, data collection, evaluation and reporting during drug, biologic and vaccine development: a report of the safety planning, evaluation, and reporting team (2009) (102)
Risk factors for pressure ulcers among elderly hip fracture patients (2003) (102)
Risk factors for the development of hyponatremia in psychiatric inpatients. (1995) (101)
The role of meta-analysis in the regulatory process for foods, drugs, and devices. (1999) (98)
Risk of lower extremity amputations in people with type 2 diabetes mellitus treated with sodium‐glucose co‐transporter‐2 inhibitors in the USA: A retrospective cohort study (2017) (98)
Delayed function reduces renal allograft survival independent of acute rejection. (1996) (97)
Randomized Trial of $5 Versus $10 Monetary Incentives, Envelope Size, and Candy to Increase Physician Response Rates to Mailed Questionnaires (2002) (96)
Racial differences in menopause information and the experience of hot flashes (1999) (96)
Declining Incidence of Ventricular Fibrillation in Myocardial Infarction: Implications for the Prophylactic Use of Lidocaine (1992) (95)
Masking author identity in peer review: what factors influence masking success? PEER Investigators. (1998) (92)
Asbestos exposure and gastrointestinal malignancy review and meta-analysis. (1988) (91)
Association of catechol-O-methyltransferase with smoking cessation in two independent studies of women (2005) (90)
Air and liquid contrast agents in the management of intussusception: a controlled, randomized trial. (1993) (89)
Hypertensive patients' willingness to participate in placebo-controlled trials: implications for recruitment efficiency. (2003) (87)
Estrogen sulfation genes, hormone replacement therapy, and endometrial cancer risk. (2006) (86)
Pediatric Crohn's disease: risk factors for postoperative recurrence (2001) (84)
When pharmaceutical manufacturers' employees present grand rounds, what do residents remember? (1996) (84)
Risk of acute first myocardial infarction and use of nicotine patches in a general population. (2001) (82)
A Comparison of Change in the 0–10 Numeric Rating Scale to a Pain Relief Scale and Global Medication Performance Scale in a Short-term Clinical Trial of Breakthrough Pain Intensity (2010) (81)
Consensus-based recommendations for investigating clinical heterogeneity in systematic reviews (2013) (79)
Who Will Enroll? Predicting Participation in a Phase II AIDS Vaccine Trial (2001) (79)
A Systematic Statistical Approach to Evaluating Evidence from Observational Studies (2014) (78)
Case-control study of postmenopausal hormone replacement therapy and endometrial cancer. (2006) (78)
Risk of venous thromboembolism from oral contraceptives containing gestodene and desogestrel versus levonorgestrel: a meta-analysis and formal sensitivity analysis. (2001) (77)
Recommendations to improve adverse event reporting in clinical trial publications: a joint pharmaceutical industry/journal editor perspective (2016) (75)
Choice of exposure scores for categorical regression in meta-analysis: a case study of a common problem (2005) (75)
Absence of an effect of injectable and implantable progestin-only contraceptives on subsequent risk of breast cancer. (2004) (71)
GI complications after orthotopic lung transplantation. (1996) (70)
Advantages and limitations of metaanalytic regressions of clinical trials data. (1992) (69)
Intrathecal therapy in tetanus. A meta-analysis. (1991) (68)
An assessment of the usefulness of the Duke criteria for diagnosing active infective endocarditis. (1997) (67)
Recipient body size and cadaveric renal allograft survival. (1996) (65)
DELTA2 guidance on choosing the target difference and undertaking and reporting the sample size calculation for a randomised controlled trial (2018) (64)
Placebo response changes depending on the neuropathic pain syndrome: results of a systematic review and meta-analysis. (2012) (63)
The association between maternal cocaine use and placenta previa. (1997) (62)
Impact of raloxifene or tamoxifen use on endometrial cancer risk: a population-based case-control study. (2008) (61)
The utility of preoperative electrocardiograms in the ambulatory surgical patient. (1992) (61)
Risk factors for clinically important adverse events after protamine administration following cardiopulmonary bypass. (1998) (60)
Cancer incidence in a group of workers potentially exposed to ethylene oxide. (1995) (60)
A guide to prospective meta-analysis (2019) (59)
Mental health of the mothers of malnourished children. (1996) (58)
Effects of L-carnitine on dialysis-related hypotension and muscle cramps: a meta-analysis. (2008) (57)
Meta-analysis of the effect of an essential oil-containing mouthrinse on gingivitis and plaque. (2015) (55)
Prevalence and Treatment of Psoriasis in the United Kingdom (2005) (54)
Meta‐analysis of randomized controlled trials as a method of estimating rare complications of non‐steroidal anti‐inflammatory drug therapy (1988) (54)
Do readers and peer reviewers agree on manuscript quality? (1994) (54)
Meta-analytic methods for pooling rates when follow-up duration varies: a case study (2004) (53)
Mortality and Adverse Events After Protamine Administration in Patients Undergoing Cardiopulmonary Bypass (2002) (53)
An international survey indicated that unpublished systematic reviews exist. (2009) (52)
DELTA 2 guidance on choosing the target difference and undertaking and reporting the sample size calculation for a randomised controlled trial (2018) (52)
Randomized trial of 5 dollars versus 10 dollars monetary incentives, envelope size, and candy to increase physician response rates to mailed questionnaires. (2002) (52)
The effect of selective serotonin re-uptake inhibitors on the risk of myocardial infarction in a cohort of patients with depression. (2011) (52)
EFFICACY OF ORAL BETA‐AGONIST MAINTENANCE THERAPY IN PRETERM LABOR: A META‐ANALYSIS (1995) (51)
Overview and experience of the YODA Project with clinical trial data sharing after 5 years (2018) (50)
STaRT-RWE: structured template for planning and reporting on the implementation of real world evidence studies (2021) (50)
Risk of major complications from coronary angioplasty performed immediately after diagnostic coronary angiography: results from the Registry of the Society for Cardiac Angiography and Interventions. (1997) (49)
Incidence of diabetic ketoacidosis among patients with type 2 diabetes mellitus treated with SGLT2 inhibitors and other antihyperglycemic agents. (2017) (48)
Hormone replacement therapy regimens and breast cancer risk(1). (2002) (48)
Inclusion of women in clinical trials (2009) (48)
Learning from electronic health records across multiple sites: A communication-efficient and privacy-preserving distributed algorithm (2019) (47)
A Randomized Controlled Trial of Financial Incentives for Smoking Cessation (2006) (46)
Assessment of the efficacy and safety of antiarrhythmic therapy for chronic atrial fibrillation: observations on the role of trial design and implications of drug-related mortality. (1992) (45)
Epidemiology : A Proposal for Reporting Meta-analysis of Observational Studies in (2000) (44)
Mannose Binding Lectin (MBL) Polymorphisms Associated with Low MBL Production in Patients with Dermatomyositis1 (2002) (44)
Adverse events after protamine administration in patients undergoing cardiopulmonary bypass: risks and predictors of under-reporting. (1998) (42)
Optimizing prediction of back pain outcomes (2013) (42)
Validation of a transfusion prediction model in head and neck cancer surgery. (2003) (41)
Wegener's granulomatosis: Possible role of environmental agents in its pathogenesis. (2004) (40)
Development and validation of simplified predictive index for major complications in contemporary percutaneous transluminal coronary angioplasty practice. The Registry Committee of the Society for Cardiac Angiography and Interventions. (1995) (39)
Effects of external beam radiation on the allograft dermal implant (2000) (38)
Evidence for magnesium sulfate as a tocolytic agent. (1997) (37)
How you look determines what you find: severity of illness and variation in blood transfusion for hip fracture. (1998) (37)
Meta-analysis of clinical trial safety data in a drug development program: Answers to frequently asked questions (2013) (37)
Statistical characteristics of area under the receiver operating characteristic curve for a simple prognostic model using traditional and bootstrapped approaches. (2002) (37)
Stroke complicating acute myocardial infarction. A meta-analysis of risk modification by anticoagulation and thrombolytic therapy. (1992) (36)
Who will enroll? Predicting participation in a phase II AIDS vaccine trial. (2001) (36)
Learning from local to global - an efficient distributed algorithm for modeling time-to-event data (2020) (36)
Risk factors for early postoperative recurrence of Crohnʼs disease (1998) (35)
Giant Gastric Ulcers and Risk Factors for Gastroduodenal Mucosal Disease in Orthotopic Lung Transplant Patients (1998) (34)
Comparison of back pain prognostic risk stratification item sets. (2014) (34)
Preventing Publication Bias: Registries and Prospective Meta‐Analysis (2006) (33)
Interobserver agreement, sensitivity, and specificity of a “healed” chronic wound (1996) (32)
Pairwise Combinations of Estrogen Metabolism Genotypes in Postmenopausal Breast Cancer Etiology (2007) (31)
Benefit–risk assessment of rivaroxaban versus enoxaparin for the prevention of venous thromboembolism after total hip or knee arthroplasty (2014) (31)
Residential proximity to electricity transmission and distribution equipment and risk of childhood leukemia, childhood lymphoma, and childhood nervous system tumors: systematic review, evaluation, and meta-analysis (1994) (31)
Risk of Cardiovascular Morbidity With Risperidone or Paliperidone Treatment: Analysis of 64 Randomized, Double-Blind Trials (2013) (30)
Bleeding risk of platelet glycoprotein IIb/IIIa receptor antagonists in broad-based practice (results from the Society for Cardiac Angiography and Interventions Registry). (2003) (30)
Relative importance of benefits and risks associated with antithrombotic therapies for acute coronary syndrome: patient and physician perspectives (2014) (30)
Prospective Meta‐Analysis (2008) (28)
Mannose binding lectin (MBL) polymorphisms associated with low MBL production in patients with dermatomyositis. (2002) (28)
Effect of ethnicity on denial of authorization for emergency department care by managed care gatekeepers. (2001) (27)
Combined effect of oral contraceptive use and hormone replacement therapy on breast cancer risk in postmenopausal women (2003) (27)
Cigarette yield and the risk of myocardial infarction in smokers. (2002) (27)
Insulin sensitizing pharmacotherapy for prevention of myocardial infarction in patients with diabetes mellitus. (2006) (26)
Diabetic ketoacidosis in patients with type 2 diabetes treated with sodium glucose co‐transporter 2 inhibitors versus other antihyperglycemic agents: An observational study of four US administrative claims databases (2019) (25)
Bumps and bridges on the road to responsible sharing of clinical trial data (2014) (25)
Assessing diagnostic criteria for active infective endocarditis. (1994) (24)
Physicians’ preferences for active-controlled versus placebo-controlled trials of new antihypertensive drugs (2002) (24)
N-of-1 clinical trials should be incorporated into clinical practice. (2010) (23)
Indications for and Outcomes of Cholecystectomy (1998) (23)
Channeling in the Use of Nonprescription Paracetamol and Ibuprofen in an Electronic Medical Records Database: Evidence and Implications (2017) (22)
Patient misunderstanding of dosing instructions (1996) (22)
Parenteral ketorolac and risk of myocardial infarction (2002) (21)
Pharmacogenetic modulation of combined hormone replacement therapy by progesterone-metabolism genotypes in postmenopausal breast cancer risk. (2007) (20)
Morphine‐augmented hepatobiliary scintigraphy: A meta‐analysis (1995) (20)
Longitudinal and repeated cross‐sectional cluster‐randomization designs using mixed effects regression for binary outcomes: bias and coverage of frequentist and Bayesian methods (2006) (20)
Risk of bleeding and hypoprothrombinaemia associated with NMTT side chain antibiotics: using cefoperazone as a test case (1999) (19)
The Utility of Preoperative Electrocardiograms in the Ambulatory Surgical Patient (1992) (19)
Class effect of angiotensin-converting enzyme inhibitors on prevention of myocardial infarction. (2004) (18)
Percutaneous injuries on the "front line": a survey of housestaff and nurses. (1994) (18)
Prospective approaches to accumulating evidence (2019) (17)
Confounding Due to Cluster in Multicenter Studies—Causes and Cures (2002) (17)
From ClinicalTrials.gov trial registry to an analysis-ready database of clinical trial results (2013) (17)
Elective hysterectomy. (1977) (16)
Facility-level variation in antibiotic prescriptions for veterans with upper respiratory infections. (2005) (16)
Risk of breast cancer associated with short-term use of oral contraceptives (2007) (15)
Use of ClinicalTrials.gov to estimate condition-specific nocebo effects and other factors affecting outcomes of analgesic trials. (2013) (15)
Meconium aspiration and other asphyxial disorders. (1978) (15)
Registration of Observational Studies: perspectives from an industry‐based epidemiology group (2011) (15)
Lack of Effect Modification between Estrogen Metabolism Genotypes and Combined Hormone Replacement Therapy in Postmenopausal Breast Cancer Risk (2007) (15)
Predicting cutaneous hypersensitivity reactions to cotrimoxazole in hiv-infected individuals receiving primary pneumocystis carinii pneumonia prophylaxis (1995) (13)
Chapter 22 : Prospective approaches to accumulating evidence (2019) (13)
Meta-analysis of branched-chain amino acids in hepatic encephalopathy. (1989) (13)
Diabetic Neuropathic Foot Ulcers (2002) (13)
Evaluation of the Association Between Hereditary Thrombophilias and Recurrent Pregnancy Loss (2016) (13)
A randomized trial provided new evidence on the accuracy and efficiency of traditional vs electronically annotated abstraction approaches in systematic reviews. (2019) (13)
Characteristics of prescribers whose patients shop for opioids: results from a cohort study. (2012) (13)
Lack of hepatotoxic effects of parenteral ketorolac in the hospital setting. (1997) (12)
Practical help for specifying the target difference in sample size calculations for RCTs: the DELTA2 five-stage study, including a workshop. (2019) (12)
Compliance with oral HRT in postmenopausal women in clinical trials--meta analysis. (2003) (12)
Evaluating Data Abstraction Assistant, a novel software application for data abstraction during systematic reviews: protocol for a randomized controlled trial (2016) (11)
Effect of histamine-2 receptor antagonists on blood alcohol levels (1998) (11)
Criteria for improvement in rheumatoid arthritis: alternatives to the American College of Rheumatology 20. (2004) (11)
Beyond Conventional Publication Bias: Other Determinants of Data Suppression (2006) (10)
Baseline characteristics and treatment-emergent risk factors associated with cerebrovascular event and death with risperidone in dementia patients (2016) (10)
Some methodological points to consider when performing systematic reviews in comparative effectiveness research (2012) (10)
Nonselective nonaspirin nonsteroidal antiinflammatory medications are associated with reduced risk of myocardial infarction (2002) (9)
Limitations of current risk-adjustment models in the era of coronary stenting. (2003) (9)
Epidemiologic studies of adverse effects of anti‐retroviral drugs: how well is statistical power reported (2005) (9)
Choosing the target difference (‘effect size’) for a randomised controlled trial - DELTA2 guidance protocol (2017) (9)
A comparison of sensitivity analyses of the effect of wound duration on wound healing. (1999) (8)
Challenges of evaluating and modelling vaccination in emerging infectious diseases (2021) (8)
Race and delayed kidney allograft function. (1998) (8)
Determining value of Coordinated Registry Networks (CRNs): a case of transcatheter valve therapies (2019) (8)
Designing, Conducting, Monitoring, and Analyzing Data from Pragmatic Randomized Clinical Trials: Proceedings from a Multi-stakeholder Think Tank Meeting (2020) (7)
Choosing the target difference and undertaking and reporting the sample size calculation for a randomised controlled trial – the development of the DELTA2 guidance (2018) (7)
Use of Adjectives in Abstracts when Reporting Results of Randomized, Controlled Trials from Industry and Academia (2015) (7)
The Use of Meta‐analysis in Pharmacoepidemiology (2013) (7)
Comparison of angiotensin-converting enzyme inhibitors and angiotensin receptor blockers in the primary prevention of myocardial infarction in hypertensive patients. (2004) (6)
Commentary: Summary statistics of poor quality studies must be treated cautiously (1997) (6)
Quantitative Benefit–Risk Assessment of Rivaroxaban for the Prevention of Venous Thromboembolism. (2009) (6)
Selective Reporting, Publication Bias and Clinical Trial Registry (2005) (6)
Intrathecal Therapy in Tetanus (2017) (6)
Changes in the use of erythropoiesis‐stimulating agents (ESAs) and red blood cell transfusion in patients with cancer amidst regulatory and reimbursement changes (2017) (6)
Effect of raloxifene on endometrial cancer risk in a population-based, case-control study (2005) (6)
Channeling Bias in the Analysis of Risk of Myocardial Infarction, Stroke, Gastrointestinal Bleeding, and Acute Renal Failure with the Use of Paracetamol Compared with Ibuprofen (2020) (5)
Using Sherlock and ClinicalTrials.gov data to understand nocebo effects and adverse event dropout rates in the placebo arm. (2013) (5)
Comparative Effectiveness of Famotidine in Hospitalized COVID-19 Patients. (2021) (5)
Comparative Effectiveness of Famotidine in Hospitalized COVID-19 Patients. (2021) (5)
Quantifying Bias in Epidemiologic Studies Evaluating the Association Between Acetaminophen Use and Cancer. (2021) (5)
A method for calculating age-weighted death proportions for comparison purposes. (1998) (5)
Risk Factors for Delayed Healing of Neuropathic Diabetic Foot Ulcers (2017) (4)
Risk of Operative Site Bleeding With Parenteral Ketorolac-Reply (1996) (4)
Sources of Data to Enable Benefit–Risk Assessment (2017) (4)
Will we ever know if leukoreduction of red blood cells should be performed? (2004) (4)
Quality of meta-analyses for randomized trials in the field of hypertension: a systematic review (2016) (4)
Selecting and Integrating Data Sources in Benefit–Risk Assessment: Considerations and Future Directions (2016) (4)
Re: "Ethics and sample size". (2005) (4)
The Use of Metaanalysis in Pharmacoepidemiology (2019) (3)
What Are Factorial Experiments and Why Can They Be Helpful? (2019) (3)
Prospective meta-analyses and Cochrane's role in embracing next-generation methodologies. (2020) (3)
Meta-analysis of small old studies of phototherapy for neonatal hyperbilirubinamia compared with a large cooperative trial (1988) (3)
Acute pancreatitis risk in type 2 diabetes patients treated with canagliflozin versus other antihyperglycemic agents: an observational claims database study (2020) (3)
Comment on “How pharmacoepidemiology networks can manage distributed analyses to improve replicability and transparency and minimize bias” (2019) (3)
Quality of Meta-Analyses for Randomized Trials in the Field of Hypertension: an Updated and Improved Systematic Review (2017) (3)
Keeping Meta-analyses Fresh. (2022) (3)
Why industry should register and disclose results of clinical studies—perspective of a recovering academic (2005) (3)
Globalized Pediatric Research (2011) (2)
Predicting Fitness Parameters from the Health Risk Appraisal (1987) (2)
An efficient design for verifying disease outcome status in large cohorts with rare exposures and low disease rates. (1999) (2)
3rd symposium on Systematic Review Methodology - Preface (2002) (2)
Risk factors for asymptomatic bacteriuria in elderly ambulatory women (1992) (2)
Replacement of central vascular catheters. (1993) (2)
Canagliflozin (CANA) vs. Other Antihyperglycemic Agents on the Risk of Below-Knee Amputation (BKA) for Patients with T2DM—A Real-World Analysis of >700,000 U.S. Patients (2018) (2)
Will publication bias vanish in the age of online journals? (1992) (2)
24. The Use of Meta-analysis in Pharmacoepidemiology (2013) (1)
Causal inference methods to assess safety upper bounds in randomized trials with noncompliance (2015) (1)
Meta-analysis of radiotherapy for small-cell lung cancer. (1993) (1)
Autor's Response (1996) (1)
PREOPERATIVE THERAPY WITH 6-MERCAPTOPURINE PREDICTS EARLY RECURRENCE FOLLOWING SURGICAL RESECTION FOR CROHN'S DISEASE IN CHILDREN: 37 (1997) (1)
Evaluating the Value of a New Prediction Model for Gastric Cancer. (2021) (1)
Protective effects of cervical screening. (1991) (1)
888-4 Angiotensin-converting enzyme inhibitors are comparable to angiotensin II receptor blockers in the primary prevention of myocardial infarction in hypertensive patients (2004) (1)
018 Healing Rate for Diabetic Neuropathic Foot Ulcer (2004) (1)
Gastrointestinal complications following orthotopic lung transplantation (1995) (1)
Prospective Meta-Analysis in Dentistry (2004) (1)
Correction to: Choosing the target difference and undertaking and reporting the sample size calculation for a randomised controlled trial – the development of the DELTA2 guidance (2019) (1)
Rheumatoid arthritis is not associated with myocardial infarction after controlling for other risk factors (2003) (1)
Meta-analysis of Alcohol and Risk of Breast Cancer-Reply (1989) (0)
1546-P: Acute Pancreatitis (AP) with Canagliflozin (CANA) vs. Other Antihyperglycemic Agents (AHAs): An Observational Study (2019) (0)
GROWTH VELOCITY AND FINAL ADULT HEIGHT FOLLOWING SURGERY FOR CROHN'S DISEASE: 36 (1997) (0)
Real-world Trends in the Evaluation of Medical Products. (2022) (0)
Original research article Absence of an effect of injectable and implantable progestin-only contraceptives on subsequent risk of breast cancer (2004) (0)
Evaluating the Potential Benefits of Using Sustained Response as a Prognostic Factor in Intermediate Hepatocellular Carcinoma Following Treatment With Conventional Chemoembolization. (2018) (0)
Registration of refugee and asylum-seeking doctors (1998) (0)
1172-67 Use of administrative databases may lead to incorrect estimates of the effects of nonaspirin nonsteroidal anti-inflammatory drugs on mlyocardial infarction risk (2004) (0)
Contributions Perioperative Blood Transfusion and Postoperative Mortality (2001) (0)
Early hemoglobin decline and survival prognosis in epoetin alfa studies. (2016) (0)
Confidence Intervals: Academia and Clinic: The Use of Predicted Confidence Intervals When Planning Experiments and the Misuse of Power When Interpreting Results (1995) (0)
The need for even further progress with clinical trial data sharing efforts: patients are waiting (2015) (0)
Angiotensin converting enzyme inhibitor tissue affinity is not associated with different risk of myocardial infarction (2003) (0)
Asbestos exposure and gastrointestinal cancer: A response (1991) (0)
PERIOPERATIVE BLOOD TRANSFUSION. AUTHOR'S REPLY (1998) (0)
Is factor V leiden mutation (FVL) associated with recurrent pregnancy loss (RPL): a meta-analysis (2002) (0)
How Confident Should We Be About Recommendations Based on Network Meta-analyses? (2019) (0)
Review for "Body mass index and risk of COVID-19 across ethnic groups: analysis of UK Biobank study" (2020) (0)
Early Hb Response to ESA Treatment May Be An Indicator of Better Survival Prognosis (2008) (0)
A comparison of mark and recapture methods for estimating animal populations (1980) (0)
CORONARY ANGIOPLASTY PROCEDURE VOLUME AND MAJOR COMPLICATIONS. AUTHORS' REPLY (1996) (0)
Validation of a measurement instrument of symptom distress for patients undergoing chemoradiation for head and neck cancer (2001) (0)
The Accuracy of Substitution Rules for Health Risk Appraisals (1990) (0)
POSTOPERATIVE RECURRENCE OF CROHN'S DISEASE IN CHILDREN: 24 (1997) (0)
Pancreatic cancer and diabetes. (1994) (0)
Articles: Asymptomatic Bacteriuria and Survival (1994) (0)
Abstract 24: Diabetic Ketoacidosis in Patients with Type 2 Diabetes Treated with Sodium Glucose Co-transporter 2 Inhibitors versus Other Antihyperglycemic Agents: An Observational Study of Four US Administrative Claims Databases (2019) (0)
Coronary Angioplasty Procedure Volume and Major Complications-Reply (1996) (0)
Infective endocarditis (IE): Dental hygiene & non-dental exposures (1997) (0)
Response to commentaries (2009) (0)
Author reply (0)
Review for "Incidence of lower extremity amputations among patients with type 1 and type 2 diabetes in the United States between 2010 and 2014" (2019) (0)
effectiveness research Some methodological points to consider when performing systematic reviews in comparative (2012) (0)
2 DELTA guidance on choosing the target difference and undertaking and reporting the sample size calculation for a randomised controlled trial (2018) (0)
REVIEW ARTICLES Searching one or two databases was insufficient for meta-analysis of observational studies (2005) (0)
The Open Translational Science in Schizophrenia (OPTICS) Project: Janssen clinical trial and NIH data together in an Open-Science collaboration (2016) (0)
The Evaluation of Adverse Events in Clinical Trials (with a Particular Focus on the Use of Meta-Analysis) (2014) (0)
Key Issues Identified by Discussion Groups (1996) (0)
Erratum: The use of predicted confidence intervals when planning experiments and the misuse of power when interpreting results (Annals of Internal Medicine (1994) 121 (200-206)) (1995) (0)
Lower myocardial infarction risk from selective serotonin reuptake inhibitors but not other antidepressants (2002) (0)
Developing a Systematic Approach to Measure Medication Adherence (2013) (0)
Interpreting Clinical Evidence (2007) (0)
DELTA (Difference ELicitation in TriAls)2 advice and recommendations for researchers and funder representatives – output from literature reviews, Delphi study, workshop and stakeholder engagement (2019) (0)
NEUROPATHIC PAIN SECTION Original Research Article Placebo Response Changes Depending on the Neuropathic Pain Syndrome: Results of a Systematic Review and Meta-Analysis (2016) (0)
Cigarette yield and the risk of myocardial infarction in smokers (2002) (0)
Conventional approach to a randomised controlled trial sample size calculation (2019) (0)
Authors' reply (2004) (0)

This paper list is powered by the following services:

What Schools Are Affiliated With Jesse A Berlin?

Jesse A Berlin is affiliated with the following schools:

Jesse A Berlin's Academic­Influence.com Rankings

Jesse A Berlin's Degrees

Why Is Jesse A Berlin Influential?

Jesse A Berlin's Published Works

Published Works

What Schools Are Affiliated With Jesse A Berlin?

Jesse A Berlin's AcademicInfluence.com Rankings